{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T16:21:04Z","timestamp":1790785264027,"version":"4.1.0"},"reference-count":78,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2006,3,1]],"date-time":"2006-03-01T00:00:00Z","timestamp":1141171200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Experimental Neurology"],"published-print":{"date-parts":[[2006,3]]},"DOI":"10.1016\/j.expneurol.2005.11.010","type":"journal-article","created":{"date-parts":[[2006,1,5]],"date-time":"2006-01-05T13:25:35Z","timestamp":1136467535000},"page":"114-128","source":"Crossref","is-referenced-by-count":34,"title":["Riluzole, unlike the AMPA antagonist RPR119990, reduces motor impairment and partially prevents motoneuron death in the wobbler mouse, a model of neurodegenerative disease"],"prefix":"10.1016","volume":"198","author":[{"given":"Elena","family":"Fumagalli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Bigini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Barbera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimiliano","family":"De Paola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiziana","family":"Mennini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.expneurol.2005.11.010_bib1","doi-asserted-by":"crossref","first-page":"137","DOI":"10.2174\/1566524043479202","article-title":"Molecular mechanisms underlying specificity of excitotoxic signaling in neurons","volume":"4","author":"Aarts","year":"2004","journal-title":"Curr. Mol. Med."},{"key":"10.1016\/j.expneurol.2005.11.010_bib2","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/0197-0186(95)00051-9","article-title":"The imbalance of brain large-chain aminoacid availability in amyotrophic lateral sclerosis patients treated with high doses of branched-chain aminoacids","volume":"27","author":"Bastone","year":"1995","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.expneurol.2005.11.010_bib3","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1046\/j.1471-4159.2001.00572.x","article-title":"Transgenic SOD1 G93A mice develop reduced GLT-1 in spinal cord without alterations in cerebrospinal fluid glutamate levels","volume":"79","author":"Bendotti","year":"2001","journal-title":"J. Neurochem."},{"key":"10.1016\/j.expneurol.2005.11.010_bib4","first-page":"77","article-title":"Late therapy with AMPA receptor antagonist ZK187638 improves the neuromuscular impairment and the survival in experimental models of motor neuron disorders","volume":"3","author":"Bendotti","year":"2002","journal-title":"Amyotroph. Lateral. Scler. Other Mot. Neuron Disord."},{"key":"10.1016\/j.expneurol.2005.11.010_bib5","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1056\/NEJM199403033300901","article-title":"A controlled trial of riluzole in amyotrophic lateral sclerosis. ALS\/Riluzole Study Group","volume":"330","author":"Bensimon","year":"1994","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.expneurol.2005.11.010_bib6","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1097\/00001756-200107030-00011","article-title":"Glutamate transporters in the spinal cord of the wobbler mouse","volume":"12","author":"Bigini","year":"2001","journal-title":"NeuroReport"},{"key":"10.1016\/j.expneurol.2005.11.010_bib7","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/BF00862977","article-title":"A double-blind placebo-controlled trial of l-threonine in amyotrophic lateral sclerosis","volume":"239","author":"Blin","year":"1992","journal-title":"J. Neurol."},{"key":"10.1016\/j.expneurol.2005.11.010_bib8","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1385\/MN:28:1:65","article-title":"The wobbler mouse: a neurodegeneration jigsaw puzzle","volume":"28","author":"Boillee","year":"2003","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.expneurol.2005.11.010_bib9","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1002\/ana.410390519","article-title":"Glutamate transporter gene expression in amyotrophic lateral sclerosis motor cortex","volume":"39","author":"Bristol","year":"1996","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.expneurol.2005.11.010_bib10","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/S0896-6273(00)80272-X","article-title":"ALS-linked SOD1 mutant G85R mediates damage to astrocytes and promotes rapidly progressive disease with SOD1-containing inclusions","volume":"18","author":"Bruijn","year":"1997","journal-title":"Neuron"},{"key":"10.1016\/j.expneurol.2005.11.010_bib11","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/S0022-3565(24)29332-0","article-title":"RPR 119990, a novel alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid antagonist: synthesis, pharmacological properties, and activity in an animal model of amyotrophic lateral sclerosis","volume":"299","author":"Canton","year":"2001","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.expneurol.2005.11.010_bib12","doi-asserted-by":"crossref","first-page":"4069","DOI":"10.1523\/JNEUROSCI.16-13-04069.1996","article-title":"Motor neurons are selectively vulnerable to AMPA\/kainate receptor-mediated injury in vitro","volume":"16","author":"Carriedo","year":"1996","journal-title":"J. Neurosci."},{"key":"10.1016\/j.expneurol.2005.11.010_bib13","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1523\/JNEUROSCI.20-01-00240.2000","article-title":"AMPA exposures induce mitochondrial Ca(2+) overload and ROS generation in spinal motor neurons in vitro","volume":"20","author":"Carriedo","year":"2000","journal-title":"J. Neurosci."},{"key":"10.1016\/j.expneurol.2005.11.010_bib14","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1097\/00001756-199404000-00040","article-title":"Neuroprotective effects of riluzole in ALS CSF toxicity","volume":"5","author":"Couratier","year":"1994","journal-title":"NeuroReport"},{"key":"10.1016\/j.expneurol.2005.11.010_bib15","doi-asserted-by":"crossref","first-page":"S233","DOI":"10.1212\/WNL.47.6_Suppl_4.233S","article-title":"The pharmacology and mechanism of action of riluzole","volume":"47","author":"Doble","year":"1996","journal-title":"Neurology"},{"key":"10.1016\/j.expneurol.2005.11.010_bib16","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/0304-3940(92)90114-M","article-title":"Pertussis toxin pretreatment abolishes the inhibitory effect of riluzole and carbachol on d-[3H]aspartate release from cultured cerebellar granule cells","volume":"140","author":"Doble","year":"1992","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.expneurol.2005.11.010_bib17","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1136\/jnnp.31.6.535","article-title":"An hereditary motor neurone disease with progressive denervation of muscle in the mouse: the mutant \u2018wobbler\u2019","volume":"31","author":"Duchen","year":"1968","journal-title":"J. Neurol., Neurosurg. Psychiatry"},{"key":"10.1016\/j.expneurol.2005.11.010_bib18","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1523\/JNEUROSCI.23-05-01688.2003","article-title":"Impaired spinal cord glutamate transport capacity and reduced sensitivity to riluzole in a transgenic superoxide dismutase mutant rat model of amyotrophic lateral sclerosis","volume":"23","author":"Dunlop","year":"2003","journal-title":"J. Neurosci."},{"key":"10.1016\/j.expneurol.2005.11.010_bib19","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1017\/S0317167100048204","article-title":"Anti-glutamate therapy in amyotrophic lateral sclerosis: a trial using lamotrigine","volume":"20","author":"Eisen","year":"1993","journal-title":"Can. J. Neurol. Sci."},{"key":"10.1016\/j.expneurol.2005.11.010_bib20","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1111\/j.1471-4159.1975.tb11895.x","article-title":"A rapid radiochemical method for the determination of choline acetyltransferase","volume":"24","author":"Fonnum","year":"1975","journal-title":"J. Neurochem."},{"key":"10.1016\/j.expneurol.2005.11.010_bib21","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/j.1600-0404.1997.tb00231.x","article-title":"A clinical trial of dextromethorphan in amyotrophic lateral sclerosis","volume":"96","author":"Gredal","year":"1997","journal-title":"Acta Neurol. Scand."},{"key":"10.1016\/j.expneurol.2005.11.010_bib22","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1002\/ana.410390203","article-title":"Benefit of vitamin E, riluzole, and gabapentin in a transgenic model of familial amyotrophic lateral sclerosis","volume":"39","author":"Gurney","year":"1996","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.expneurol.2005.11.010_bib23","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1212\/WNL.50.1.62","article-title":"Riluzole preserves motor function in a transgenic model of familial amyotrophic lateral sclerosis","volume":"50","author":"Gurney","year":"1998","journal-title":"Neurology"},{"key":"10.1016\/j.expneurol.2005.11.010_bib24","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1046\/j.1471-4159.1995.65031199.x","article-title":"Excess extracellular and low intracellular glutamate in poorly differentiating wobbler astrocytes and astrocyte recovery in glutamine-depleted culture medium","volume":"65","author":"Hantaz-Ambroise","year":"1995","journal-title":"J. Neurochem."},{"key":"10.1016\/j.expneurol.2005.11.010_bib25","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1038\/363266a0","article-title":"Neurotrophins promote motor neuron survival and are present in embryonic limb bud","volume":"363","author":"Henderson","year":"1993","journal-title":"Nature"},{"key":"10.1016\/j.expneurol.2005.11.010_bib26","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1002\/ana.410360619","article-title":"High-dose dextromethorphan in amyotrophic lateral sclerosis: phase I safety and pharmacokinetic studies","volume":"36","author":"Hollander","year":"1994","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.expneurol.2005.11.010_bib27","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1016\/S0022-3565(24)36931-9","article-title":"Effects of the neuroprotective agent riluzole on the high voltage-activated calcium channels of rat dorsal root ganglion neurons","volume":"282","author":"Huang","year":"1997","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.expneurol.2005.11.010_bib28","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1126\/science.1653450","article-title":"Identification of a site in glutamate receptor subunits that controls calcium permeability","volume":"253","author":"Hume","year":"1991","journal-title":"Science"},{"key":"10.1016\/j.expneurol.2005.11.010_bib29","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1002\/ana.410370413","article-title":"Effects of brain-derived neurotrophic factor on motor dysfunction in wobbler mouse motor neuron disease","volume":"37","author":"Ikeda","year":"1995","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.expneurol.2005.11.010_bib30","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.brainres.2004.06.002","article-title":"Riluzole slows the progression of neuromuscular dysfunction in the wobbler mouse motor neuron disease","volume":"1019","author":"Ishiyama","year":"2004","journal-title":"Brain Res."},{"key":"10.1016\/j.expneurol.2005.11.010_bib31","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1006\/mcne.1998.0708","article-title":"Regulation of growth factor gene expression in degenerating motoneurons of the murine mutant wobbler: a cellular patch-sampling\/RT-PCR study","volume":"12","author":"Junier","year":"1998","journal-title":"Mol. Cell. Neurosci."},{"key":"10.1016\/j.expneurol.2005.11.010_bib32","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1096\/fj.02-0143fje","article-title":"Riluzole enhances expression of brain-derived neurotrophic factor with consequent proliferation of granule precursor cells in the rat hippocampus","volume":"16","author":"Katoh-Semba","year":"2002","journal-title":"FASEB J."},{"key":"10.1016\/j.expneurol.2005.11.010_bib33","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/PL00005241","article-title":"Riluzole, a glutamate release inhibitor, and motor behavior","volume":"358","author":"Kretschmer","year":"1998","journal-title":"Naunyn-Schmiedeberg's Arch. Pharmacol."},{"key":"10.1016\/j.expneurol.2005.11.010_bib34","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1017\/S0317167100041652","article-title":"Excitatory amino acid receptor antagonist in murine motoneuron disease (the wobbler mouse)","volume":"19","author":"Krieger","year":"1992","journal-title":"Can. J. Neurol. Sci."},{"key":"10.1016\/j.expneurol.2005.11.010_bib35","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1002\/ana.10500","article-title":"Efficient three-drug cocktail for disease induced by mutant superoxide dismutase","volume":"53","author":"Kriz","year":"2003","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.expneurol.2005.11.010_bib36","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1016\/S0140-6736(96)91680-3","article-title":"Dose-ranging study of riluzole in amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis\/Riluzole Study Group II","volume":"347","author":"Lacomblez","year":"1996","journal-title":"Lancet"},{"key":"10.1016\/j.expneurol.2005.11.010_bib37","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1006\/exnr.2001.7653","article-title":"GluR2 AMPA receptor subunit expression in motoneurons at low and high risk for degeneration in amyotrophic lateral sclerosis","volume":"169","author":"Laslo","year":"2001","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.expneurol.2005.11.010_bib38","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/0014-2999(93)90037-I","article-title":"The neuroprotective agent riluzole inhibits release of glutamate and aspartate from slices of hippocampal area CA1","volume":"250","author":"Martin","year":"1993","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.expneurol.2005.11.010_bib39","series-title":"Excitotoxicity in Neurological Diseases: New Therapeutic Challenge","first-page":"217","article-title":"Excitotoxicity in amyotrophic lateral sclerosis: selective vulnerability of motor neurons","author":"Mennini","year":"2004"},{"key":"10.1016\/j.expneurol.2005.11.010_bib40","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1046\/j.1460-9568.1999.00588.x","article-title":"Biochemical and pharmacological evidence of a functional role of AMPA receptors in motor neuron dysfunction in mnd mice","volume":"11","author":"Mennini","year":"1999","journal-title":"Eur. J. Neurosci."},{"issue":"Suppl. 1","key":"10.1016\/j.expneurol.2005.11.010_bib41","first-page":"133","article-title":"Riluzole protects against motor neuron degeneration in the wobbler mice","volume":"4","author":"Mennini","year":"2003","journal-title":"Amyotroph. Lateral. Scler. Other Mot. Neuron Disord."},{"key":"10.1016\/j.expneurol.2005.11.010_bib42","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/S0301-0082(97)00055-5","article-title":"Molecular biology of glutamate receptors in the central nervous system and their role in excitotoxicity, oxidative stress and aging","volume":"54","author":"Michaelis","year":"1998","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.expneurol.2005.11.010_bib43","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1212\/WNL.47.6.1383","article-title":"Placebo-controlled trial of gabapentin in patients with amyotrophic lateral sclerosis. WALS Study Group. Western Amyotrophic Lateral Sclerosis Study Group","volume":"47","author":"Miller","year":"1996","journal-title":"Neurology"},{"key":"10.1016\/j.expneurol.2005.11.010_bib44","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1080\/14660820310002601","article-title":"Riluzole for amyotrophic lateral sclerosis (ALS)\/motor neuron disease (MND)","volume":"4","author":"Miller","year":"2003","journal-title":"Amyotroph. Lateral. Scler. Other Mot. Neuron Disord."},{"issue":"Pt. 4","key":"10.1016\/j.expneurol.2005.11.010_bib45","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1093\/brain\/105.4.811","article-title":"Murine motor neuron disease (the wobbler mouse): degeneration and regeneration of the lower motor neuron","volume":"105","author":"Mitsumoto","year":"1982","journal-title":"Brain"},{"key":"10.1016\/j.expneurol.2005.11.010_bib46","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1002\/(SICI)1097-4598(199908)22:8<1000::AID-MUS2>3.0.CO;2-Q","article-title":"Neurotrophic factors and neuro-muscular disease: II. GDNF, other neurotrophic factors, and future directions","volume":"22","author":"Mitsumoto","year":"1999","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.expneurol.2005.11.010_bib47","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1002\/ana.410360205","article-title":"The effects of ciliary neurotrophic factor on motor dysfunction in wobbler mouse motor neuron disease","volume":"36","author":"Mitsumoto","year":"1994","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.expneurol.2005.11.010_bib48","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0304-3940(01)02098-5","article-title":"Riluzole stimulates nerve growth factor, brain-derived neurotrophic factor and glial cell line-derived neurotrophic factor synthesis in cultured mouse astrocytes","volume":"310","author":"Mizuta","year":"2001","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.expneurol.2005.11.010_bib49","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1006\/nbdi.2000.0297","article-title":"A novel neuroprotective mechanism of riluzole: direct inhibition of protein kinase C","volume":"7","author":"Noh","year":"2000","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.expneurol.2005.11.010_bib50","first-page":"47","article-title":"New mechanisms of excitatory transmitter neurotoxicity","volume":"43","author":"Olney","year":"1994","journal-title":"J. Neural Transm., Suppl."},{"key":"10.1016\/j.expneurol.2005.11.010_bib51","doi-asserted-by":"crossref","first-page":"10499","DOI":"10.1073\/pnas.89.21.10499","article-title":"Switch in glutamate receptor subunit gene expression in CA1 subfield of hippocampus following global ischemia in rats","volume":"89","author":"Pellegrini-Giampietro","year":"1992","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.expneurol.2005.11.010_bib52","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/S0166-2236(97)01100-4","article-title":"The GluR2 (GluR-B) hypothesis: Ca(2+)-permeable AMPA receptors in neurological disorders","volume":"20","author":"Pellegrini-Giampietro","year":"1997","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.expneurol.2005.11.010_bib53","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S0304-3940(97)00384-4","article-title":"Riluzole promotes survival of rat motoneurons in vitro by stimulating trophic activity produced by spinal astrocyte monolayers","volume":"228","author":"Peluffo","year":"1997","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.expneurol.2005.11.010_bib54","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/0003-2697(77)90043-4","article-title":"A simplification of the protein assay method of Lowry et al. which is more generally applicable","volume":"83","author":"Peterson","year":"1977","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.expneurol.2005.11.010_bib55","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1002\/(SICI)1096-9861(19970901)385:3<456::AID-CNE9>3.0.CO;2-2","article-title":"Glutamate receptor subunit 2-selective antibody shows a differential distribution of calcium-impermeable AMPA receptors among populations of neurons","volume":"385","author":"Petralia","year":"1997","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.expneurol.2005.11.010_bib56","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1002\/ana.410220503","article-title":"Abnormal glutamate metabolism in amyotrophic lateral sclerosis","volume":"22","author":"Plaitakis","year":"1987","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.expneurol.2005.11.010_bib57","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/0306-4522(93)90004-Y","article-title":"Alterations of the GluR-B AMPA receptor subunit flip\/flop expression in kainate-induced epilepsy and ischemia","volume":"57","author":"Pollard","year":"1993","journal-title":"Neuroscience"},{"key":"10.1016\/j.expneurol.2005.11.010_bib58","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1046\/j.1471-4159.1995.64010462.x","article-title":"Down-regulation of AMPA receptor subunit GluR2 in amygdaloid kindling","volume":"64","author":"Prince","year":"1995","journal-title":"J. Neurochem."},{"key":"10.1016\/j.expneurol.2005.11.010_bib59","doi-asserted-by":"crossref","first-page":"S19","DOI":"10.1212\/WNL.47.4_Suppl_2.19S","article-title":"Excitotoxicity hypothesis","volume":"47","author":"Rothstein","year":"1996","journal-title":"Neurology"},{"key":"10.1016\/j.expneurol.2005.11.010_bib60","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1002\/ana.410280106","article-title":"Abnormal excitatory amino acid metabolism in amyotrophic lateral sclerosis","volume":"28","author":"Rothstein","year":"1990","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.expneurol.2005.11.010_bib61","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1056\/NEJM199205283262204","article-title":"Decreased glutamate transport by the brain and spinal cord in amyotrophic lateral sclerosis","volume":"326","author":"Rothstein","year":"1992","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.expneurol.2005.11.010_bib62","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/ana.410380114","article-title":"Selective loss of glial glutamate transporter GLT-1 in amyotrophic lateral sclerosis","volume":"38","author":"Rothstein","year":"1995","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.expneurol.2005.11.010_bib63","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1006\/neur.1995.0026","article-title":"CSF and plasma amino acid levels in motor neuron disease: elevation of CSF glutamate in a subset of patients","volume":"4","author":"Shaw","year":"1995","journal-title":"Neurodegeneration"},{"key":"10.1016\/j.expneurol.2005.11.010_bib64","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/S0306-4522(03)00212-4","article-title":"Creatine supplementation and riluzole treatment provide similar beneficial effects in copper, zinc superoxide dismutase (G93A) transgenic mice","volume":"119","author":"Snow","year":"2003","journal-title":"Neuroscience"},{"key":"10.1016\/j.expneurol.2005.11.010_bib65","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1212\/WNL.47.5.1220","article-title":"A controlled trial of amino acid therapy in amyotrophic lateral sclerosis: I. Clinical, functional, and maximum isometric torque data","volume":"47","author":"Tandan","year":"1996","journal-title":"Neurology"},{"key":"10.1016\/j.expneurol.2005.11.010_bib66","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/0006-8993(94)91805-8","article-title":"Quantitative autoradiographic distribution of glutamate receptors in the cervical segment of the spinal cord of the wobbler mouse","volume":"650","author":"Tomiyama","year":"1994","journal-title":"Brain Res."},{"key":"10.1016\/j.expneurol.2005.11.010_bib67","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1002\/mus.1029","article-title":"Role of brain-derived neurotrophic factor in wobbler mouse motor neuron disease","volume":"24","author":"Tsuzaka","year":"2001","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.expneurol.2005.11.010_bib68","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0304-3940(03)00314-8","article-title":"The AMPA receptor antagonist NBQX prolongs survival in a transgenic mouse model of amyotrophic lateral sclerosis","volume":"343","author":"Van Damme","year":"2003","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.expneurol.2005.11.010_bib69","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1523\/JNEUROSCI.20-01-00123.2000","article-title":"AMPA receptor calcium permeability, GluR2 expression, and selective motoneuron vulnerability","volume":"20","author":"Vandenberghe","year":"2000","journal-title":"J. Neurosci."},{"key":"10.1016\/j.expneurol.2005.11.010_bib70","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1046\/j.0953-816x.2001.01648.x","article-title":"Subcellular localization of calcium-permeable AMPA receptors in spinal motoneurons","volume":"14","author":"Vandenberghe","year":"2001","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.expneurol.2005.11.010_bib71","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1002\/1098-1136(200010)32:1<84::AID-GLIA80>3.0.CO;2-Q","article-title":"Dying neural cells activate glia through the release of a protease product","volume":"32","author":"Viviani","year":"2000","journal-title":"Glia"},{"key":"10.1016\/j.expneurol.2005.11.010_bib72","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.neuroscience.2004.01.019","article-title":"Mechanisms underlying the riluzole inhibition of glutamate release from rat cerebral cortex nerve terminals (synaptosomes)","volume":"125","author":"Wang","year":"2004","journal-title":"Neuroscience"},{"key":"10.1016\/j.expneurol.2005.11.010_bib73","doi-asserted-by":"crossref","first-page":"9393","DOI":"10.1523\/JNEUROSCI.17-24-09393.1997","article-title":"Differential dependence on GluR2 expression of three characteristic features of AMPA receptors","volume":"17","author":"Washburn","year":"1997","journal-title":"J. Neurosci."},{"key":"10.1016\/j.expneurol.2005.11.010_bib74","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1523\/JNEUROSCI.16-06-01982.1996","article-title":"Evidence for multiple AMPA receptor complexes in hippocampal CA1\/CA2 neurons","volume":"16","author":"Wenthold","year":"1996","journal-title":"J. Neurosci."},{"key":"10.1016\/j.expneurol.2005.11.010_bib75","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1002\/ana.410420211","article-title":"Calcium-permeable alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid receptors: a molecular determinant of selective vulnerability in amyotrophic lateral sclerosis","volume":"42","author":"Williams","year":"1997","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.expneurol.2005.11.010_bib76","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/S0022-3565(24)29322-8","article-title":"Neuroprotective agent riluzole dramatically slows inactivation of Kv1.4 potassium channels by a voltage-dependent oxidative mechanism","volume":"299","author":"Xu","year":"2001","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.expneurol.2005.11.010_bib77","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1038\/360753a0","article-title":"Brain-derived neurotrophic factor rescues spinal motor neurons from axotomy-induced cell death","volume":"360","author":"Yan","year":"1992","journal-title":"Nature"},{"key":"10.1016\/j.expneurol.2005.11.010_bib78","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/S0306-4522(97)00604-0","article-title":"Riluzole interacts with voltage-activated sodium and potassium currents in cultured rat cortical neurons","volume":"85","author":"Zona","year":"1998","journal-title":"Neuroscience"}],"container-title":["Experimental Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014488605004206?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014488605004206?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,6]],"date-time":"2025-01-06T22:33:08Z","timestamp":1736202788000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014488605004206"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,3]]},"references-count":78,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2006,3]]}},"alternative-id":["S0014488605004206"],"URL":"https:\/\/doi.org\/10.1016\/j.expneurol.2005.11.010","relation":{},"ISSN":["0014-4886"],"issn-type":[{"value":"0014-4886","type":"print"}],"subject":[],"published":{"date-parts":[[2006,3]]}}}